Detalles de la búsqueda
1.
Achieving osteoporosis treat-to-target goals with teriparatide or alendronate: sub-analysis of Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
J Bone Miner Metab
; 42(3): 382-388, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755328
2.
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.
J Bone Miner Metab
; 42(2): 143-154, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538869
3.
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
Osteoporos Int
; 34(1): 189-199, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239756
4.
Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene.
Calcif Tissue Int
; 112(4): 430-439, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707436
5.
Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
J Bone Miner Metab
; 41(6): 854-864, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897672
6.
Fracture risk associated with glucocorticoid-induced osteoporosis in Japan.
J Bone Miner Metab
; 40(4): 636-647, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546370
7.
Efficacy of once-weekly teriparatide for primary prevention of glucocorticoid-induced osteoporosis: A post hoc analysis of the TOWER-GO study.
Mod Rheumatol
; 32(3): 634-640, 2022 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910192
8.
Family caregiver burden of patients with osteoporotic fracture in Japan.
J Bone Miner Metab
; 39(4): 612-622, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595773
9.
Efficacy of once-weekly teriparatide in patients with glucocorticoid-induced osteoporosis: the TOWER-GO study.
J Bone Miner Metab
; 39(3): 446-455, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211212
10.
Epidemiology of glucocorticoid-induced osteoporosis and management of associated fracture risk in Japan.
J Bone Miner Metab
; 39(6): 1019-1030, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125296
11.
Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies.
Mod Rheumatol
; 31(1): 34-41, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826682
12.
Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA).
J Bone Miner Metab
; 38(4): 522-532, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140784
13.
Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study.
J Bone Miner Metab
; 38(4): 511-521, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970477
14.
Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR.
J Bone Miner Metab
; 38(2): 141-144, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020289
15.
Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis.
J Bone Miner Metab
; 38(1): 86-98, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420748
16.
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.
Ann Rheum Dis
; 78(7): 899-907, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036625
17.
Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies.
Calcif Tissue Int
; 104(2): 193-200, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30343436
18.
Changes in quality of life in patients with postmenopausal osteoporosis receiving weekly bisphosphonate treatment: a 2-year multicenter study in Japan.
J Bone Miner Metab
; 37(2): 273-281, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523963
19.
Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid.
J Bone Miner Metab
; 37(5): 886-892, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30719580
20.
Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04.
J Bone Miner Metab
; 37(3): 491-495, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019249